CPRX — Catalyst Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $3.85bn
- $3.10bn
- $588.99m
Brief: Catalyst Pharmaceuticals FY Revenue USD 491.7 Million Vs. IBES Estimate USD 484.1 Million
Brief: Catalyst Pharmaceuticals Announces Settlement Of FIRDAPSE (Amifampridine) Patent Litigation With Teva Pharmaceuticals
U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix
Catalyst Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Catalyst Pharmaceuticals Q3 Revenue USD 128.7 Million Vs. IBES Estimate USD 123.4 Million
Catalyst Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Catalyst Pharmaceuticals Q2 Revenue USD 122.7 Million Vs. IBES Estimate USD 111.9 Million
Catalyst Pharmaceuticals Inc expected to post earnings of 26 cents a share - Earnings Preview
Brief: Catalyst Pharmaceuticals Enters Into Agreement With Kye Pharmaceuticals For Agamree® In Canada
Catalyst Pharmaceuticals Inc expected to post earnings of 26 cents a share - Earnings Preview
Catalyst Pharmaceuticals Inc expected to post earnings of 26 cents a share - Earnings Preview
Catalyst Pharmaceuticals Inc expected to post earnings of 26 cents a share - Earnings Preview
Catalyst Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Catalyst Pharmaceuticals Inc expected to post earnings of 17 cents a share - Earnings Preview
Brief: Catalyst Pharmaceuticals Says Drug To Treat Rare Muscular Dystrophy Now Commercially Available In The US
U.S. STOCKS ON THE MOVE-Children's Place, Bath & Body Works, Best Buy
U.S. STOCKS ON THE MOVE-Boeing, Chemours, C3.ai
U.S. STOCKS ON THE MOVE-Voyager Therapeutics, GoodRx Holdings, Tenet Healthcare
U.S. STOCKS ON THE MOVE-Okta, Duolingo, Birkenstock